CEO transition at Merck: Effective May 1, 2026, @KaiBeckmann is set to take over from Belén Garijo to become the Chair of the Executive Board and CEO.
ms.spr.ly/6015sSsGU
Merck CEO Belén Garijo shares key highlights from our financial results published today. We delivered profitable growth.
More info about our #MerckFinancialResults: ms.spr.ly/6013qGfU1
Our financial results for the full year 2024: We returned to profitable growth and delivered on our guidance.
More info about our #MerckFinancialResults: ms.spr.ly/6014qGfu4
Almost ready! Tomorrow, we will announce our financial results of the fourth quarter and full-year 2024.
• 7 a.m. CET: Publication of the financial results
• 10 a.m. CET: Annual press conference
• 2 p.m. CET: Conference call for analysts
More info: ms.spr.ly/6015q1QDZ
Announcing an important evolution of our company’s Executive Board. New CEOs for Life Science and Healthcare business sectors and appointment of Chief People Officer to the Executive Board. Read full announcement here: ms.spr.ly/6015UvYLx
ALT Important evolution of our company’s Executive Board
ALT Important evolution of our company’s Executive Board
ALT Important evolution of our company’s Executive Board
ALT Important evolution of our company’s Executive Board
Taking a moment to highlight some of the amazing work from our Women’s Employee Resource Groups (ERGs) across globe. Our Women’s Employee Resource Group (ERG) in Taiwan and WomenatMerck Network in Germany support female leadership and career growth. #WomenInSTEM#Leaders
Merck is looking confidently toward the future: At today’s Capital Markets Day, we reiterated our expectation of returning to profitable and financially strong growth in the coming years. ms.spr.ly/6016mCEGM#CapitalMarketsDay
ALT Belén Garijo presenting at Capital Markets Day
We proudly handed over this year's Merck Awards! The Merck Awards celebrate outstanding achievements. As always, the winning teams were honored at the Global Leadership Summit. #Awards
We're thrilled to announce the grand opening of our new Learning Center in Darmstadt today! This space will serve as a hub for learning, collaboration, and innovation. Join us in marking this significant milestone! #MerckLearningCenter#Darmstadt#GrandOpening
Today, we announced the first patient dosed in the Phase III study evaluating an oral treatment for generalised Myasthenia Gravis.
#MyastheniaGravis is a rare, chronic autoimmune neuromuscular disorder, resulting in muscle weakness.
Learn more: ms.spr.ly/6016lAXIK
We celebrate 100 years of Merck in Spain 🇪🇸: In 1922 we have a branch in Barcelona, from which we found the company "Productos Quimico-Farmacéuticos" in 1924. 1936-39 we produced in Vigo, which was discontinued after reopening in Barcelona.
#ThrowbackThursday#tbt#Spain
Tomorrow, we will announce our financial results for the second quarter of 2024 at 7 a.m. (CEST). Our conference call for the media will take place at 9:30 a.m. (CEST), and the conference call for analysts at 2 p.m. (CEST). Read more: merckgroup.com/en/media-cent…#MerckResults
Our Innovation Cup brought together students & young professionals worldwide to learn from experts & work on innovative projects. Congrats to this year's winners for their outstanding project! #InnovationCup